Left ventricular thrombi form due to the presence of Virchow’s triad in patients with left ventricular systolic dysfunction. This complication increases the incidence of systemic embolization, hence anticoagulation is recommended to decrease this risk. Up to the present time, vitamin K antagonists are recommended by all societal guidelines for patients with left ventricular thrombi. Recently, several studies have investigated the role of different anticoagulants and yielded promising outcomes. This opinion article focuses on the evidence supporting vitamin K antagonists and direct oral anticoagulants in patients with left ventricular thrombi.

中文翻译：

---

直接口服抗凝剂对比维生素 K 拮抗剂治疗左心室血栓

由于左心室收缩功能障碍患者存在 Virchow 三联征而形成左心室血栓。这种并发症会增加全身栓塞的发生率，因此建议使用抗凝药物来降低这种风险。迄今为止，所有社会指南都推荐维生素 K 拮抗剂用于左心室血栓患者。最近，几项研究调查了不同抗凝剂的作用并产生了有希望的结果。这篇观点文章的重点是支持左心室血栓患者使用维生素 K 拮抗剂和直接口服抗凝剂的证据。